A Comparison of the Pharmacological Profile of AT7519 in Solid Tumour and Haematological Cell Lines. Author(s) MS Squires, R E Feltell, V Lock, D Smith, EJ Lewis, J Higgins, M Yule, D M Cross, NT Thompson, JF Lyons

First Page		Document Content
Date: 2012-12-13 18:06:00 Proteins Retinoblastoma protein Cyclin Apoptosis CDK inhibitor Cell cycle checkpoint Protein P16 Biology Cell biology Cell cycle		A Comparison of the Pharmacological Profile of AT7519 in Solid Tumour and Haematological Cell Lines. Author(s) MS Squires, R E Feltell, V Lock, D Smith, EJ Lewis, J Higgins, M Yule, D M Cross, NT Thompson, JF Lyons Add to Reading List Source URL: astx.com Download Document from Source Website File Size: 150,88 KB Share Document on Facebook

	Microsoft PowerPoint - Figure 1 Final 1.ppt DocID: 1a9KF - View Document
	Mathematical Modeling of Transcription Regulation by Protein Assemblies at Promoters: Regulation of E2F Dependent Genes Paul Brazhnik Kurt Kohn DocID: 18zbz - View Document
	Witkiewicz and Knudsen Breast Cancer Research 2014, 16:207 http://breast-cancer-research.com/contentREVIEW Retinoblastoma tumor suppressor pathway in DocID: 15VU3 - View Document
	Microsoft Word - Citations+Links_Apr15_FS.docx DocID: 151H3 - View Document
	Single-cell E2F Dynamics Reveal the Control Logic of Cell Cycle Entry Peng Dong1, Manoj V. Maddali2, Jaydeep K. Srimani2, Bernard Mathey-Prevot3 and Lingchong You4 Short Abstract — To explore the molecular events respo DocID: 13vZq - View Document